2022 - Research.com Medicine in South Africa Leader Award
2019 - Fellow of the Royal Society, United Kingdom
2012 - Member of the National Academy of Medicine (NAM)
2009 - Fellow, The World Academy of Sciences
Member of the Association of American Physicians
Fellow of the Royal Society of South Africa
His primary areas of study are Immunology, Virology, Acquired immunodeficiency syndrome, Antibody and Epitope. His studies link Gp41 with Virology. His biological study spans a wide range of topics, including Psychological intervention, Young adult, Internal medicine, Demography and Public health.
Salim S. Abdool Karim combines subjects such as Microbicides for sexually transmitted diseases, Rectal microbicide, Surgery and Pre-exposure prophylaxis with his study of Internal medicine. Salim S. Abdool Karim has included themes like Cross-sectional study, Condom and Incidence in his Demography study. The Public health study combines topics in areas such as Transmission, Health care and Developing country.
Salim S. Abdool Karim mostly deals with Virology, Immunology, Acquired immunodeficiency syndrome, Antibody and Viral load. The study incorporates disciplines such as Epitope, Microbicides for sexually transmitted diseases and Microbicide in addition to Virology. His Immunology research integrates issues from Bacterial vaginosis and Cohort.
His study in Acquired immunodeficiency syndrome is interdisciplinary in nature, drawing from both Incidence, Demography, Family medicine, Transmission and Public health. His work deals with themes such as Internal medicine and Viral replication, which intersect with Viral load. His research investigates the link between Internal medicine and topics such as Tuberculosis that cross with problems in Clinical trial.
Salim S. Abdool Karim focuses on Virology, Viral load, Immunology, Antibody and Internal medicine. His studies in Virology integrate themes in fields like Epitope, HIV vaccine and Coronavirus disease 2019. His Viral load study incorporates themes from Lipopolysaccharide binding protein, Point-of-care testing, Task shifting and Tuberculosis.
His Immunology study combines topics from a wide range of disciplines, such as Bacterial vaginosis and Reproductive health. His research investigates the connection with Antibody and areas like Trogocytosis which intersect with concerns in Antigenic variation. As a member of one scientific family, Salim S. Abdool Karim mostly works in the field of Pharmacokinetics, focusing on Phases of clinical research and, on occasion, Acquired immunodeficiency syndrome.
The scientist’s investigation covers issues in Viral load, Virology, Internal medicine, Immunology and Tuberculosis. His Viral load research is multidisciplinary, incorporating perspectives in Clinical trial, MEDLINE, Treatment outcome, Regimen and Intensive care medicine. His Regimen research includes elements of Demography, Sequence analysis, Drug resistance and Acquired immunodeficiency syndrome.
The Virus research he does as part of his general Virology study is frequently linked to other disciplines of science, such as Limiting, therefore creating a link between diverse domains of science. His studies deal with areas such as Test, Point of care, Task shifting and Point-of-care testing as well as Internal medicine. Salim S. Abdool Karim has researched Tuberculosis in several fields, including HIV drug resistance, Tolerability, Cohort study and Dolutegravir.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
Quarraisha Abdool Karim;Salim S. Abdool Karim;Salim S. Abdool Karim;Salim S. Abdool Karim;Janet A. Frohlich;Anneke C. Grobler.
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial
Lut Van Damme;Gita Ramjee;Michel Alary;Bea Vuylsteke.
The Lancet (2002)
Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
Salim S. Abdool Karim;Kogieleum Naidoo;Anneke Grobler;Nesri Padayatchi.
The New England Journal of Medicine (2010)
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia
Georgia D. Tomaras;Nicole L. Yates;Pinghuang Liu;Li Qin.
Journal of Virology (2008)
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.
Nicole A. Doria-Rose;Chaim A. Schramm;Jason Gorman;Penny L. Moore.
Health in South Africa: changes and challenges since 2009
Bongani M. Mayosi;Joy E. Lawn;Ashley. Van Niekerk;Ashley. Van Niekerk;Debbie. Bradshaw.
The Lancet (2012)
HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.
Salim Safurdeen. Abdool Karim;Salim Safurdeen. Abdool Karim;Gavin J. Churchyard;Quarraisha. Abdool Karim;Quarraisha. Abdool Karim;Stephen D. Lawn.
The Lancet (2009)
Integration of antiretroviral therapy with tuberculosis treatment
Salim Safurdeen. Abdool Karim;Kogieleum. Naidoo;Anna Christina. Grobler;Nesri. Padayatchi.
The New England Journal of Medicine (2011)
The impact of migration on HIV-1 transmission in South Africa: a study of migrant and nonmigrant men and their partners.
Mark N. Lurie;Brian G. Williams;Khangelani Zuma;David Mkaya-Mwamburi.
The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection
Elin S. Gray;Maphuti C. Madiga;Tandile. Hermanus;Penny L. Moore.
Journal of Virology (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: